Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.98 percent. This is a 35 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $39.766 million which beat the analyst consensus estimate of $36.886 million by 7.81 percent. This is a 10.42 percent increase over sales of $36.013 million the same period last year.
精彩评论